TAK1/MAP4K2 inhibitor 1 is a potent dual TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2) inhibitor, with IC50s of 41.1 nM and 18.2 nM, respectively.
性状
Solid
IC50 & Target[1][2]
TAK1
41.1 nM (IC50)
MAP4K2
18.2 nM (IC50)
体内研究(In Vivo)
TAK1/MAP4K2 inhibitor 1 has moderate terminal elimination half-life (t1/2=2.94 h for mice (1 mg/kg, iv)).
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.